Both in Biotechnology
Precision BioSciences vs Fate Therapeutics
Over the past year DTIL returned +21.4% and FATE returned +75.6%; their daily moves had a correlation of 0.26.
DTIL +21.4% FATE +75.6%Growth of $1, one year, split-adjusted
| Metric | DTIL | FATE |
|---|---|---|
| Price | $8.12 | $2.09 |
| Market cap | $224.1M | $250.4M |
| Today | +16.50% | +2.45% |
| 1 month | +31.0% | −8.7% |
| 6 months | +8.0% | −8.7% |
| Year to date | +95.2% | +112.7% |
| 1 year | +10.3% | +65.9% |
| Revenue growth (YoY) | −100.0% | +9.2% |
| Gross margin | — | 100.0% |
| Net margin | — | −1448.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 38.6× |
| Net cash | $65.1M | $153.8M |
| Dividend yield | — | — |
| Volatility (60d) | 70.1% | 56.4% |
| Short % of float | 9.1% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).